Table 2.
Sample sizea | Platform | No. pCNC | pCNC % | |
---|---|---|---|---|
AUS only studies | ||||
Tyreman et al.5 | 106 | Affymetrix Gene Chip 6.0 | 11 | 10.4 |
D'Amours et al.6 | 49 | BAC/105 and 135k oligo | 6 | 12.2 |
Evangelidou et al.7 | 15 | 1 Mb BAC | 2 | 13.3 |
Valduga et al.8 | 50 | 44k oligo | 5 | 10.0 |
Faas et al.9 | 30 | 250k SNP | 2 | 6.7 |
Srebniak et al.10 | 199 | 105k SNP | 16 | 8.0 |
Le Caignec et al.11 | 49 | BAC targeted | 3 | 6.1 |
Rooryck et al.12 | 142 | 60k oligo | 16 | 11.3 |
Subtotal | 640 | 61 | 9.5 | |
Other studies | ||||
Wapner et al.14 | 755 | Targeted with 1 Mb backbone | 45 | 6.0 |
Shaffer et al.15 | 2081 | Various | 131 | 6.3 |
Lee et al.16 | 180 | BAC targeted/60k oligo | 20 | 11.1 |
Fiorentino et al.17 | 74 | BAC targeted | 5 | 6.8 |
Subtotal | 3090 | 201 | 6.5 | |
Combined studies | 3730 | 262 | 7.0 |
Normal conventional karyotypes only.